Sage Rhino Capital »

Takeda Pharmaceutical shares owned by Sage Rhino Capital

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Sage Rhino Capital from 13F filings

Historical chart of Sage Rhino Capital investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Sage Rhino Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Sage Rhino Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $164k 12k 13.89
2023-09-30 $182k 12k 15.47
2023-06-30 $172k 11k 15.71
2023-03-31 $177k 11k 16.48

More positions owned by Sage Rhino Capital

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Gold Tr Ishares New (IAU)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Core Msci Eafe (IEFA)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Spdr Ser Tr S&p Divid Etf (SDY)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Apple (AAPL)
American Centy Etf Tr Us Eqt Etf (AVUS)
Vincerx Pharma Com New (VINC)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)

View all positions for Sage Rhino Capital

Top funds holding Takeda Pharmaceutical

Mondrian Investment Partners
Morgan Stanley
Goldman Sachs Group
Brandes Investment Partners
FMR
Millennium Management
BlackRock
Northern Trust
Citadel Advisors
Van Eck Associates Corp.
Managed Asset Portfolios
Envestnet Asset Management
Bank of America Corporation
Causeway Capital Management
Arrowstreet Capital, Limited Partnership

View all funds holding Takeda Pharmaceutical